für 18.01€ kaufen ···· Acadia ROSEN, SKILLED INVESTOR COUNSEL, Encourages Acadia Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before ...[weiter] ····· ····· ····· ····· ····· ····· 1062750
für 24.01€ kaufen ···· Acadia The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors[weiter] ····· ····· ····· ····· ····· 1062749
für 20.01€ kaufen ···· Acadia SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action ...[weiter] ····· ····· ····· ····· ····· 1062748
für 20.01€ kaufen ···· Acadia SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action ...[weiter] ····· ····· ····· ····· ····· 1062747
für 21.01€ kaufen ···· Acadia Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia ...[weiter] ····· ····· ····· ····· ····· ····· 1062746
für 20.01€ kaufen ···· Acadia SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action ...[weiter] ····· ····· ····· ····· ····· 1062745
für 20.01€ kaufen ···· Acadia Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)[weiter] ····· ····· ····· ····· ····· ····· 1062744
für 20.01€ kaufen ···· Acadia SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action ...[weiter] ····· ····· ····· ····· ····· 1062743
für 24.01€ kaufen ···· Acadia The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors[weiter] ····· ····· ····· ····· ····· 1062742
für 20.01€ kaufen ···· Acadia SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action ...[weiter] ····· ····· ····· ····· ····· 1062741· 1 ·